41 results
8-K
EX-99.1
ACET
Adicet Bio Inc
10 Nov 22
Regulation FD Disclosure
5:09pm
. Oncotarget (2017) Groh et al. PNAS (1999) CLL: Chronic lymphocytic leukemia; MM: Multiple myeloma; MCC: Merkel cell carcinoma, TNBC: Triple negative
8-K
ACET
Adicet Bio Inc
6 Jun 22
Adicet Bio Reports Emerging Data from ADI-001 Phase 1 Trial at the American Society of Clinical Oncology Annual Meeting
4:01pm
ADI-001 initial dosing (months)
Prior CAR T?
BOR by Lugano Criteria 2014
DL 1
30 million CAR+ cells
62/F
Transformed DLBCL
(from chronic
8-K
EX-99.1
ACET
Adicet Bio Inc
6 Jun 22
Adicet Bio Reports Emerging Data from ADI-001 Phase 1 Trial at the American Society of Clinical Oncology Annual Meeting
4:01pm
chronic lymphocytic leukemia)
5 prior lines
6
No
PD
66/F
Transformed high grade
B-cell lymphoma (from follicular lymphoma)
4 prior lines
6
No
CR
8-K
817b2nd8k0t96oplb4s
6 Dec 21
Other Events
7:55am
424B5
ik900y7qv7q4zevb9
11 Feb 21
Prospectus supplement for primary offering
5:20pm
424B5
c029g
10 Feb 21
Prospectus supplement for primary offering
12:00am
424B5
hjk046o3oxeuhy5k
1 Dec 20
Prospectus supplement for primary offering
5:28pm
424B5
srxyl qfzzy
21 Sep 20
Prospectus supplement for primary offering
7:58am
8-K
EX-99.4
nqhh9akof
16 Sep 20
Entry into a Material Definitive Agreement
9:59am
8-K
EX-99.1
lejyh2 nl52v5
28 May 20
Regulation FD Disclosure
8:00am
8-K
EX-99.1
x9zeosk4n0k6 tql
19 Feb 20
Regulation FD Disclosure
8:06am
8-K
EX-99.1
12lixv0c8y9lg3 lg
18 Nov 19
Regulation FD Disclosure
7:30am
8-K
EX-99.1
yhldf536cr767kkb
15 Nov 19
Other Events
7:31am